Companies /Industrials

Emerson Electric Company

NYSE: EMR Specialty Industrial Machinery
$150.19
▲ $1.21 (+0.81%) today
Markets closed · 6:22pm ET

Q1 2026 Earnings

Reported Feb 3, 2026, 4:05pm ET · SEC source
$1.46
Beat +3.39%
EPS · est. $1.41
$4.3B
Miss −0.06%
Revenue · est. $4.3B
−9.2%
Trailing market
EMR vs S&P since report
6 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
0+3%+6%Feb 3Feb 4report 4:05pm ETearnings−0.2%+3.7%
0+3%+6%Feb 3Feb 4earnings−0.2%+3.7%
EMR +3.7%S&P 500 −0.2%
−3%0+3%+6%Feb 3Feb 4report 4:05pm ETearnings−1.2%+3.7%
−3%0+3%+6%Feb 3Feb 4earnings−1.2%+3.7%
EMR +3.7%NASDAQ −1.2%
−6%−3%0+3%Feb 2Feb 11report 4:05pm ETearnings+0.5%−1.8%
−6%−3%0+3%Feb 2Feb 11earnings+0.5%−1.8%
EMR −1.8%S&P 500 +0.5%
−6%−3%0+3%Feb 2Feb 11report 4:05pm ETearnings−0.4%−1.8%
−6%−3%0+3%Feb 2Feb 11earnings−0.4%−1.8%
EMR −1.8%NASDAQ −0.4%
+3.43%
Day of report
−4.06%
Next session
−1.68%
One week
−10.30%
30 days

S&P 500 over the same 30 days: −1.15%.

Did EMR Beat Earnings? Q1 2026 Results

Emerson Electric delivered a profitability beat in fiscal Q1 2026, with adjusted EPS of $1.46 clearing the $1.41 consensus estimate by 3.39%, even as net sales of $4.35 billion came in essentially flat against expectations, up 4.1% year-over-year. The standout driver behind the earnings strength was Test and Measurement, which posted 14% reported sales growth and saw its adjusted segment EBITA margin expand sharply to 29.7% from 25.5% a year ago, underscoring the premium profitability of Emerson's evolving automation technology portfolio. Orders momentum remained a bright spot, with underlying orders growing 9% for the fourth consecutive quarter, led by demand from North America, India, and the Middle East and Africa. Institutional sentiment has been mixed, with some investors trimming positions even as others added exposure ahead of results. Looking ahead, Emerson guided for full-year net sales growth of approximately 5.5% and adjusted EPS of $6.40 to $6.55, with Q2 adjusted EPS expected in the $1.50 to $1.55 range and roughly $2.20 billion targeted for shareholder returns.

Key Takeaways
  • Fourth consecutive quarter of strong underlying orders growth at 9%
  • Robust demand for automation technology led by Software & Systems
  • Strength in North America, India, and the Middle East & Africa
  • Test & Measurement segment delivered 14% reported and 11% underlying sales growth
  • Adjusted segment EBITA margin of 27.7% despite 30 bps decline

“Emerson met sales commitments and exceeded expectations for profitability as our global teams continue to execute well. We delivered a fourth consecutive quarter of strong underlying orders growth, and we are experiencing robust demand for our automation technology, led by Software & Systems, with strength in North America, India and the Middle East & Africa.”

Emerson Electric CEO, on the earnings call

Forward Guidance & Outlook

For fiscal year 2026, Emerson expects net sales growth of approximately 5.5%, underlying sales growth of approximately 4%, GAAP EPS of $4.78–$4.93, and adjusted EPS of $6.40–$6.55. For Q2 2026, net sales growth is expected at 3%–4%, underlying sales growth of 1%–2%, GAAP EPS of $1.06–$1.11, and adjusted EPS of $1.50–$1.55. Full-year operating cash flow is projected at $4.0B–$4.1B, free cash flow of $3.5B–$3.6B, and approximately $1.0B in share repurchases. The company plans to return approximately $2.2B to shareholders through buybacks and dividends.

EMR YoY Financials

Q1 2026 vs Q1 2025 · SEC filings Q1 2025 Q1 2026
$0$2.0B$4.0B$4.2B$4.3BRevenue$2.2B$2.3BGross Profit$585.0M$605.0MNet Income
$0$2.0B$4.0BRevenueGross ProfitNet Income

EMR Revenue by Segment

Intelligent Devices$2.4B+4.0%
Software & Systems$1.5B+5.0%
Final Control$1.4B+4.0%
Control Systems & Software$1.0B+2.0%
Measurement & Analytical
Sensors$996.0M+2.0%
Discrete Automation
Safety & Productivity$503.0M+3.0%

Figures from SEC filings and company reports. Not investment advice.